NYSE:FMS Fresenius Medical Care AG & Co. KGaA Q1 2026 Earnings Results & Report $21.96 -0.27 (-1.19%) As of 11:25 AM Eastern This is a fair market value price provided by Massive. Learn more. Fresenius Medical Care AG & Co. KGaA reported Q1 2026 earnings on March 31, 2026. The company reported EPS of $1.0530, while revenue was $5.34 billion. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2026Report DateMarch 31, 2026TimeAfter Market Closes Fresenius Medical Care AG & Co. KGaA EPS ResultsActual EPS$1.0530Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEPS Beat Rate6 of last 8 quartersFresenius Medical Care AG & Co. KGaA Revenue ResultsActual Revenue$5.34 billionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Fresenius Medical Care AG & Co. KGaA Q1 2026 Earnings FAQ Did Fresenius Medical Care AG & Co. KGaA beat earnings estimates for Q1 2026? Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) reported earnings of $1.0530 per share for Q1 2026. The report was announced on Tuesday, March 31, 2026. What was Fresenius Medical Care AG & Co. KGaA's revenue for Q1 2026? Fresenius Medical Care AG & Co. KGaA reported revenue of $5.34 billion for Q1 2026. Fresenius Medical Care AG & Co. KGaA Earnings HeadlinesFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Share Price Crosses Below 200 Day Moving Average After Analyst DowngradeNovember 12 at 1:41 AM | americanbankingnews.comFresenius announces intention to sell approximately 13.4 million shares in Fresenius Medical Care AG, reducing its financial investment to approximately 20 per centNovember 11 at 1:34 PM | marketscreener.comMDemocrats can stall every bill. They can’t stop this Trump order.The U.S. owns 8,133 tonnes of gold, still valued on the books at $42.22 an ounce. That price was set in 1973 and never updated. Legal experts say Trump potentially has the authority to correct that with one executive order. No act of Congress is required, even with Democrats now controlling the House and Senate. The last time Washington reset its relationship with gold, gold gained 2,300% in under a decade.November 12 at 1:00 AM | Priority Gold (Ad)Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Moved Down to Underweight by BarclaysNovember 10 at 3:43 AM | americanbankingnews.comFresenius Medical Care AG & Co. KGaA (FMS) vs. Its Rivals Financial ContrastNovember 10 at 2:15 AM | americanbankingnews.comFresenius Medical Care AG 2026 Q3 - Results - Earnings Call PresentationNovember 5, 2026 | seekingalpha.comSee More Fresenius Medical Care AG & Co. KGaA Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Fresenius Medical Care AG & Co. KGaA? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fresenius Medical Care AG & Co. KGaA and other key companies, straight to your email. Email Address About Fresenius Medical Care AG & Co. KGaAFresenius Medical Care AG & Co. KGaA (NYSE:FMS) is a healthcare company focused on treating people with chronic kidney failure. It provides dialysis care through a global network of treatment centers and supports patients who receive care in clinics or at home. The company also develops and supplies products used in dialysis, including dialysis machines, dialyzers, and related medical equipment and materials. Its services include clinical care and support for healthcare providers involved in kidney treatment. Formed in 1996 through the combination of Fresenius’s dialysis business and National Medical Care, Fresenius Medical Care serves patients and healthcare providers across multiple regions, including North America, Europe, Latin America, and Asia-Pacific.View Fresenius Medical Care AG & Co. KGaA ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffKeeping AI Cool: AAON Rides the AI Heatwave to Record GrowthPalantir’s Real Washington Risk Isn’t the Budget—It’s OversightCan Constellation Energy's Contracts Power a Stock Rebound?IonQ Raised the Bar, But 3 Quantum Rivals Face Tough QuestionsAmazon's Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI Demand Upcoming Earnings Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
